• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>American Medical Journal >Insulin Pump Therapy in Type 1 Diabetes-Merging Technology with Diabetes Care | Science Publications
【24h】

Insulin Pump Therapy in Type 1 Diabetes-Merging Technology with Diabetes Care | Science Publications

机译：合并糖尿病的1型糖尿病合并胰岛素泵疗法|科学出版物

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

> The use of insulin pump therapy has been increasing over the past number of years in many countries. The Diabetes Control and Complications Trial (DCCT) have proven that better glycaemic control with fewer hypoglycemic events is achievable with insulin pump therapy. The delivery of subcutaneous insulin through an insulin pump mimics physiological insulin delivery better than Multiple Daily Injection of insulin (MDI). Insulin pump therapy is an attractive therapeutic option for many patients with T1DM with the potential to improve glycaemic control and quality of life. Technological developments over the past few years have enhanced the functional capabilities and appearance of modern insulin pumps. Careful patient selection for insulin pump therapy by health care professionals is still important, to optimize its benefit and to lessen the associated risk. In this review article, the clinical evidence for insulin pumps, its advantages and disadvantages, as well as patient selection criteria for insulin pumps are outlined. Examples of insulin pump devices that are currently available, including the advent of newer devices and technology in this field are also reviewed.
机译： >在过去的许多年中，胰岛素泵疗法的使用一直在增加。糖尿病控制和并发症试验（DCCT）已证明，采用胰岛素泵治疗可实现更好的血糖控制，同时减少低血糖事件。通过胰岛素泵皮下注射胰岛素比每天多次注射胰岛素（MDI）更好地模拟了生理胰岛素的递送。对于许多T1DM患者来说，胰岛素泵疗法是一种有吸引力的治疗选择，它有可能改善血糖控制和生活质量。过去几年的技术发展增强了现代胰岛素泵的功能和外观。医护人员对胰岛素泵疗法进行仔细的患者选择仍然很重要，以优化其益处并降低相关风险。在这篇综述文章中，概述了胰岛素泵的临床证据，其优缺点以及胰岛素泵的患者选择标准。还回顾了当前可用的胰岛素泵设备的示例，包括该领域中更新设备和技术的出现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号